Cleared Traditional

K133937 - HEARTSCAN SOFTWARE

K133937 is an FDA 510(k) clearance for HEARTSCAN SOFTWARE, manufactured by Morpheus Imaging, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 70-day FDA review.

K133937 · Morpheus Imaging, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2014
Decision
70d
Days
Class 2
Risk

K133937 is an FDA 510(k) clearance for the HEARTSCAN SOFTWARE. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Morpheus Imaging, Inc. (San Francisco, US). The FDA issued a Cleared decision on March 3, 2014 after a review of 70 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Morpheus Imaging, Inc. devices

FDA 510(k) Submission Details - K133937

510(k) Number K133937 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 2013
Decision Date March 03, 2014
Days to Decision 70 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 107d · This submission: 70d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1236
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K133937.
NIO COLOR 2MP
K133663 · Barco N.V. · Mar 2014
SYNO MR NEUROLOGY, SYNGO MR ONCOLOGY, SYNGO. MR BREVIS, SYNGO MMR GENERAL
K133401 · Siemens Medical Solutions USA, Inc. · Mar 2014
IMPAX VOLUME VIEWING 3.0
K133135 · Agfa Healthcare N.V. · Mar 2014
ADVANCED VIEWER
K132763 · Brainlab AG · Feb 2014
SCENIUM
K133654 · Siemens Medical Solutions USA, Inc. · Feb 2014
SYNGO.VIA MI WORKFLOWS
K133644 · Siemens Medical Solutions USA, Inc. · Feb 2014